Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA
NCT02160535Phase 3Terminated
- Sponsor
- University of Washington
- Start
- May 2014
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in chronic post-traumatic headache (CPTHA), sponsored by University of Washington. Started May 2014; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
chronic post-traumatic headache (CPTHA)
Beyond the preview
Go deeper on NCT02160535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160535.